Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme

Food and Chemical Toxicology

Volumn 45, Issue 3, 2007, Pages 508-514

  Bednar, Wolfgang ^a   Holzmann, Klaus ^a   Marian, Brigitte ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

12(S) HETE; 12(S) Lipoxygenase; ELISA

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONIC ACID; BAICALEIN; KAEMPFEROL; NORDIHYDROGUAIARETIC ACID; QUERCETIN; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CELL STRAIN; COLORECTAL CANCER; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL;

APOPTOSIS; ARACHIDONATE 12-LIPOXYGENASE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA PRIMERS; HUMANS; LIPOXYGENASE INHIBITORS; PHYTOTHERAPY; PLANTS, MEDICINAL; POLYMERASE CHAIN REACTION; PROTECTIVE AGENTS; RNA;

EID: 33846578787     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2006.08.013     Document Type: Article

References (32)

1. Anderson K.M., Ondrey F., and Harris J.E. Do lipoxygenases modulate normal or aberrant lympho-hematopoiesis?. Leukemia Res. 23 (1999) 51-56
2. Brash A.R. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274 (1999) 23679-23682
3. Dubois R.N. Review article: cyclooxygenase-a target for colon cancer prevention. Aliment. Pharmacol. Therap. 14 Suppl 1 (2000) 64-67
4. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
5. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
6. Galfi P., Neogrady Z., Amberger A., Margreiter R., and Csordas A. Sensitization of colon cancer cell lines to butyrate-mediated proliferation inhibition by combined application of indomethacin and nordihydroguaiaretic acid. Cancer Detect. Prev. 29 (2005) 276-285
7. Gupta R.A., and Dubois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer 1 (2001) 11-21
8. Hausott B., Greger H., and Marian B. Naturally occurring lignans efficiently induce apoptosis in colorectal tumor cells. J. Cancer Res. Clin. Oncol. 129 (2003) 569-576
9. Jankun J., Aleem A.M., Malgorzewicz S., Szkudlarek M., Zavodszky M.I., Dewitt D.L., Feig M., Selman S.H., and Skrzypczak-Jankun E. Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells. Mol. Cancer Therap. 5 (2006) 1371-1382
10. Kennedy T.J., Chan C.Y., Ding X.Z., and Adrian T.E. Lipoxygenase inhibitors for the treatment of pancreatic cancer. Expert Rev. Anticancer Therap. 3 (2003) 525-536
11. Krieg P., Kinzig A., Ress-Loschke M., Vogel S., Vanlandingham B., Stephan M., Lehmann W.D., Marks F., and Furstenberger G. 12-Lipoxygenase isoenzymes in mouse skin tumor development. Mol. Carcinog. 14 (1995) 118-129
12. Leuhuber K., Klepal W., Hausott B., and Marian B. Apoptosis in a tissue-like culture model of human colorectal adenoma cells. Tissue Cell 38 (2006) 203-208
13. Marks F., and Furstenberger G. Cancer chemoprevention through interruption of multistage carcinogenesis. The lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur. J. Cancer 36 (2000) 314-329
14. Muller K., Siebert M., Heidt M., Marks F., Krieg P., and Furstenberger G. Modulation of epidermal tumor development caused by targeted overexpression of epidermis-type 12S-lipoxygenase. Cancer Res. 62 (2002) 4610-4616
15. Nie D., and Honn K.V. Cyclooxygenase, lipoxygenase and tumor angiogenesis. Cell Mol. Life Sci. 59 (2002) 799-807
16. Nie D., and Honn K.V. Eicosanoid regulation of angiogenesis in tumors. Semin. Thromb. Hemost. 30 (2004) 119-125
17. Nie D., Che M., Grignon D., Tang K., and Honn K.V. Role of eicosanoids in prostate cancer progression. Cancer Metast. Rev. 20 (2001) 195-206
18. Nogata Y., Yoza K., Kusumoto K., Kohyama N., Sekiya K., and Ohta H. Screening for Inhibitory Activity of Citrus Fruit Extracts against Platelet Cyclooxygenase and Lipoxygenase. J. Agric. Food Chem. 44 (1996) 725-729
19. O'Prey J., Brown J., Fleming J., and Harrison P.R. Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells. Biochem. Pharmacol. 66 (2003) 2075-2088
20. Prieto J.M., Recio M.C., Giner R.M., Manez S., Giner-Larza E.M., and Rios J.L. Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions. J. Pharm. Pharmacol. 55 (2003) 1275-1282
21. Richter M., Ebermann R., and Marian B. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutr. Cancer 34 (1999) 88-99
22. Richter M., Weiss M., Weinberger I., Furstenberger G., and Marian B. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis 22 (2001) 17-25
23. Richter M., Jurek D., Wrba F., Kaserer K., Wurzer G., Karner-Hanusch J., and Marian B. Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Eur. J. Cancer 38 (2002) 1937-1945
24. Rioux N., and Castonguay A. Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis 19 (1998) 1393-1400
25. Shureiqi I., and Lippman S.M. Lipoxygenase modulation to reverse carcinogenesis. Cancer Res. 61 (2001) 6307-6312
26. Shureiqi I., Chen D., Lotan R., Yang P., Newman R.A., Fischer S.M., and Lippman S.M. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res. 60 (2000) 6846-6850
27. Steele V.E., Holmes C.A., Hawk E.T., Kopelovich L., Lubet R.A., Crowell J.A., Sigman C.C., and Kelloff G.J. Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 467-483
28. Tong W.G., Ding X.Z., and Adrian T.E. The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem. Biophys. Res. Commun. 296 (2002) 942-948
29. Tong W.G., Ding X.Z., Witt R.C., and Adrian T.E. Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol. Cancer Therap. 1 (2002) 929-935
30. Willson J.K., Bittner G.N., Oberley T.D., Meisner L.F., and Weese J.L. Cell culture of human colon adenomas and carcinomas. Cancer Res. 47 (1987) 2704-2713
31. Wong B.C., Wang W.P., Cho C.H., Fan X.M., Lin M.C., Kung H.F., and Lam S.K. 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells. Carcinogenesis 22 (2001) 1349-1354
32. Yoshimura R., Inoue K., Kawahito Y., Mitsuhashi M., Tsuchida K., Matsuyama M., Sano H., and Nakatani T. Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor. Int. J. Mol. Med. 13 (2004) 41-46